Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 176

1.

Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity-a comparative study with papillary renal cell carcinoma.

Kim SS, Cho YM, Kim GH, Kee KH, Kim HS, Kim KM, Kim JH, Choi C.

Mod Pathol. 2020 Jan 17. doi: 10.1038/s41379-019-0420-8. [Epub ahead of print]

PMID:
31953522
2.

Comprehensive analyses of safety and efficacy toward individualizing imatinib dosage in patients with chronic myeloid leukemia.

Shin H, Choi SY, Kee KM, Kim SH, Yang SY, Jung SY, Noh H, Zang DY, Kim DW, Lee JI.

Int J Hematol. 2019 Dec 20. doi: 10.1007/s12185-019-02805-9. [Epub ahead of print]

PMID:
31863342
3.

Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4.

Liang J, Wang N, He J, Du J, Guo Y, Li L, Wu W, Yao C, Li Z, Kee K.

Elife. 2019 Nov 11;8. pii: e48767. doi: 10.7554/eLife.48767.

4.

The influence of direct-acting antivirals in hepatitis C virus related hepatocellular carcinoma after curative treatment.

Kuo YH, Wang JH, Chang KC, Hung CH, Lu SN, Hu TH, Yen YH, Kee KM, Chen CH.

Invest New Drugs. 2019 Nov 8. doi: 10.1007/s10637-019-00870-9. [Epub ahead of print]

PMID:
31701431
5.

Using AST-platelet ratio index and fibrosis 4 index for detecting chronic hepatitis C in a large-scale community screening.

Kuo YH, Kee KM, Hsu NT, Wang JH, Hsiao CC, Chen Y, Lu SN.

PLoS One. 2019 Oct 22;14(10):e0222196. doi: 10.1371/journal.pone.0222196. eCollection 2019.

6.

Predictive Effects of Inflammatory Scores in Patients with BCLC 0-A Hepatocellular Carcinoma after Hepatectomy.

Huang PY, Wang CC, Lin CC, Lu SN, Wang JH, Hung CH, Kee KM, Chen CH, Chen KD, Hu TH, Tsai MC.

J Clin Med. 2019 Oct 14;8(10). pii: E1676. doi: 10.3390/jcm8101676.

7.

Active hepatocellular carcinoma is an independent risk factor of direct-acting antiviral treatment failure: A retrospective study with prospectively collected data.

Yen YH, Chen CH, Hung CH, Wang JH, Lu SN, Kee KM, Hu TH.

PLoS One. 2019 Oct 3;14(10):e0222605. doi: 10.1371/journal.pone.0222605. eCollection 2019.

8.

Electronic acute medical take - small measures to improve transparency, management, flow and efficiency; a model for the future hospital.

Lux D, Darnell R, Kee K, Burke C.

Future Healthc J. 2019 Jun;6(Suppl 2):63. doi: 10.7861/futurehosp.6-2s-s63. No abstract available.

9.

Risk factor analysis on the healing time and infection rate of diabetic foot ulcers in a referral wound care clinic.

Kee KK, Nair HKR, Yuen NP.

J Wound Care. 2019 Jan 1;28(Sup1):S4-S13. doi: 10.12968/jowc.2019.28.Sup1.S4.

PMID:
30724120
10.

Sustained virological response and metabolic risk factors are associated with mortality in patients with chronic hepatitis C.

Yen YH, Kee KM, Chen CH, Hu TH, Lu SN, Wang JH, Hung CH.

PLoS One. 2019 Jan 9;14(1):e0208858. doi: 10.1371/journal.pone.0208858. eCollection 2019.

11.

A scoring system to predict HBsAg seroclearance in hepatitis B and C coinfected patients treated with interferon and ribavirin in an Asian cohort.

Yen YH, Kee KM, Kuo FY, Chang KC, Hu TH, Lu SN, Wang JH, Hung CH, Chen CH.

Medicine (Baltimore). 2018 Dec;97(50):e13383. doi: 10.1097/MD.0000000000013383.

12.

Clinical characteristics and prognosis of HCC occurrence after antiviral therapy for HCV patients between sustained and non-sustained responders.

Sou FM, Wu CK, Chang KC, Lu SN, Wang JH, Hung CH, Chen CH, Kee KM, Yen YH, Lin MT, Tsai MC, Hu TH.

J Formos Med Assoc. 2019 Jan;118(1 Pt 3):504-513. doi: 10.1016/j.jfma.2018.10.017. Epub 2018 Dec 4.

13.

Risk of Postpolypectomy Bleeding With Uninterrupted Clopidogrel Therapy in an Industry-Independent, Double-Blind, Randomized Trial.

Chan FKL, Kyaw MH, Hsiang JC, Suen BY, Kee KM, Tse YK, Ching JYL, Cheong PK, Ng D, Lam K, Lo A, Lee V, Ng SC.

Gastroenterology. 2019 Mar;156(4):918-925.e1. doi: 10.1053/j.gastro.2018.10.036. Epub 2018 Oct 25.

PMID:
30518511
14.

Comparison of Commonly Used Questionnaires to Identify Obstructive Sleep Apnea in a High-Risk Population.

Kee K, Dixon J, Shaw J, Vulikh E, Schlaich M, Kaye DM, Zimmet P, Naughton MT.

J Clin Sleep Med. 2018 Dec 15;14(12):2057-2064. doi: 10.5664/jcsm.7536.

15.

Compound mutations involving T315I and P-loop mutations are the major components of multiple mutations detected in tyrosine kinase inhibitor resistant chronic myeloid leukemia.

Kang KH, Kim SH, Choi SY, Yoo HL, Lee MY, Song HY, Kee KM, Suh JH, Yang SY, Jang EJ, Lee SE, Kim DW.

Leuk Res. 2019 Jan;76:87-93. doi: 10.1016/j.leukres.2018.10.019. Epub 2018 Nov 27.

PMID:
30503643
16.

Did AFP-L3 save ultrasonography in community screening?

Yen CW, Kuo YH, Wang JH, Chang KC, Kee KM, Hung SF, Chen Y, Tsai LS, Chen SC, Hung CH, Lu SN.

Kaohsiung J Med Sci. 2018 Oct;34(10):583-587. doi: 10.1016/j.kjms.2018.05.005. Epub 2018 Jun 11.

17.

Association between chronic viral hepatitis and metabolic syndrome in southern Taiwan: a large population-based study.

Kuo YH, Kee KM, Wang JH, Hsu NT, Hsiao CC, Chen Y, Lu SN.

Aliment Pharmacol Ther. 2018 Nov;48(9):993-1002. doi: 10.1111/apt.14960. Epub 2018 Sep 11.

PMID:
30277595
18.

BCR-ABL1 transcript levels at 4 weeks have prognostic significance for time-specific responses and for predicting survival in chronic-phase chronic myeloid leukemia patients treated with various tyrosine kinase inhibitors.

Song HY, Noh H, Choi SY, Lee SE, Kim SH, Kee KM, Yoo HL, Lee MY, Kang KH, Suh JH, Yang SY, Jang EJ, Lee JI, Kim DW.

Cancer Med. 2018 Oct;7(10):5107-5117. doi: 10.1002/cam4.1753. Epub 2018 Aug 31.

19.

Social vs. non-social measures of learning potential for predicting community functioning across phase of illness in schizophrenia.

Clayson PE, Kern RS, Nuechterlein KH, Knowlton BJ, Bearden CE, Cannon TD, Fiske AP, Ghermezi L, Hayata JN, Hellemann GS, Horan WP, Kee K, Lee J, Subotnik KL, Sugar CA, Ventura J, Yee CM, Green MF.

Schizophr Res. 2019 Feb;204:104-110. doi: 10.1016/j.schres.2018.07.046. Epub 2018 Aug 16.

PMID:
30121183
20.

A review on interventions to reduce medication discrepancies or errors in primary or ambulatory care setting during care transition from hospital to primary care.

Kee KW, Char CWT, Yip AYF.

J Family Med Prim Care. 2018 May-Jun;7(3):501-506. doi: 10.4103/jfmpc.jfmpc_196_17. Review.

21.

Diabetes is associated with advanced fibrosis and fibrosis progression in non-genotype 3 chronic hepatitis C patients.

Yen YH, Kuo FY, Kee KM, Chang KC, Tsai MC, Hu TH, Lu SN, Wang JH, Hung CH, Chen CH.

Dig Liver Dis. 2019 Jan;51(1):142-148. doi: 10.1016/j.dld.2018.07.003. Epub 2018 Jul 17.

PMID:
30076015
22.

Misoprostol Heals Small Bowel Ulcers in Aspirin Users With Small Bowel Bleeding.

Kyaw MH, Otani K, Ching JYL, Higashimori A, Kee KM, Watanabe T, Tse YK, Lee V, Tanigawa T, Cheong PK, Suen BY, Fujiwara Y, Lam K, Arakawa T, Chan FKL.

Gastroenterology. 2018 Oct;155(4):1090-1097.e1. doi: 10.1053/j.gastro.2018.06.056. Epub 2018 Sep 5.

PMID:
29966612
23.

APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level.

Yen YH, Kuo FY, Kee KM, Chang KC, Tsai MC, Hu TH, Lu SN, Wang JH, Hung CH, Chen CH.

PLoS One. 2018 Jun 28;13(6):e0199760. doi: 10.1371/journal.pone.0199760. eCollection 2018.

24.

Characteristics of patients who progress from bridging to long-term oxygen therapy.

Levin K, Borg B, Miller B, Kee K, Dabscheck E.

Intern Med J. 2018 Nov;48(11):1376-1381. doi: 10.1111/imj.13737.

PMID:
29345397
25.

Episodic Memory for Dynamic Social Interaction Across Phase of Illness in Schizophrenia.

Lee J, Nuechterlein KH, Knowlton BJ, Bearden CE, Cannon TD, Fiske AP, Ghermezi L, Hayata JN, Hellemann GS, Horan WP, Kee K, Kern RS, Subotnik KL, Sugar CA, Ventura J, Yee CM, Green MF.

Schizophr Bull. 2018 Apr 6;44(3):620-630. doi: 10.1093/schbul/sbx081.

26.

Association between PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma in Asian chronic hepatitis C patients: A longitudinal study.

Yen YH, Tsai MC, Wu CK, Chang KC, Hung CH, Chiu KW, Lu SN, Wang JH, Chen CH, Kee KM, Kuo YH, Tseng PL, Lin MT, Huang CM, Lin JT, Hu TH.

J Formos Med Assoc. 2018 Sep;117(9):833-840. doi: 10.1016/j.jfma.2017.10.003. Epub 2017 Oct 28.

27.

Sequence variants of KHDRBS1 as high penetrance susceptibility risks for primary ovarian insufficiency by mis-regulating mRNA alternative splicing.

Wang B, Li L, Zhu Y, Zhang W, Wang X, Chen B, Li T, Pan H, Wang J, Kee K, Cao Y.

Hum Reprod. 2017 Oct 1;32(10):2138-2146. doi: 10.1093/humrep/dex263.

PMID:
28938739
28.

Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C.

Huang CM, Chang KC, Hung CH, Chiu KW, Lu SN, Wang JH, Chen CH, Kee KM, Kuo YH, Tsai MC, Tseng PL, Lin MT, Wu CK, Hu TH, Cho CL, Yen YH.

PLoS One. 2017 Aug 10;12(8):e0182204. doi: 10.1371/journal.pone.0182204. eCollection 2017.

29.

A Randomized Controlled Trial of Glycyrrhizin Plus Tenofovir vs. Tenofovir in Chronic Hepatitis B with Severe Acute Exacerbation.

Hung CH, Kee KM, Chen CH, Tseng PL, Tsai MC, Chen CH, Wang JH, Chang KC, Kuo YH, Yen YH, Hu TH, Lu SN.

Clin Transl Gastroenterol. 2017 Jun 29;8(6):e104. doi: 10.1038/ctg.2017.29.

30.

Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients.

Lee MH, Huang CF, Lai HC, Lin CY, Dai CY, Liu CJ, Wang JH, Huang JF, Su WP, Yang HC, Kee KM, Yeh ML, Chuang PH, Hsu SJ, Huang CI, Kao JT, Chen CC, Chen SH, Jeng WJ, Yang HI, Yuan Y, Lu SN, Sheen IS, Liu CH, Peng CY, Kao JH, Yu ML, Chuang WL, Chen CJ.

Sci Rep. 2017 Jun 16;7(1):3718. doi: 10.1038/s41598-017-02313-y.

31.

In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells.

Jung D, Xiong J, Ye M, Qin X, Li L, Cheng S, Luo M, Peng J, Dong J, Tang F, Shen W, Matzuk MM, Kee K.

Nat Commun. 2017 Jun 12;8:15680. doi: 10.1038/ncomms15680.

32.

Baseline BCR-ABL1 transcript type of e13a2 and large spleen size are predictors of poor long-term outcomes in chronic phase chronic myeloid leukemia patients who failed to achieve an early molecular response after 3 months of imatinib therapy.

Lee SE, Choi SY, Kim SH, Song HY, Yoo HL, Lee MY, Hwang HJ, Kang KH, Kee KM, Jang EJ, Kim DW.

Leuk Lymphoma. 2018 Jan;59(1):105-113. doi: 10.1080/10428194.2017.1320711. Epub 2017 May 25.

PMID:
28540759
33.

Andrographolide induces apoptotic and non-apoptotic death and enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in gastric cancer cells.

Lim SC, Jeon HJ, Kee KH, Lee MJ, Hong R, Han SI.

Oncol Lett. 2017 May;13(5):3837-3844. doi: 10.3892/ol.2017.5923. Epub 2017 Mar 27.

34.

The outcome of sorafenib monotherapy on hepatocellular carcinoma with portal vein tumor thrombosis.

Kuo YH, Wu IP, Wang JH, Hung CH, Rau KM, Chen CH, Kee KM, Hu TH, Lu SN.

Invest New Drugs. 2018 Apr;36(2):307-314. doi: 10.1007/s10637-017-0468-6. Epub 2017 May 2.

PMID:
28466374
35.

Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial.

Chan FKL, Ching JYL, Tse YK, Lam K, Wong GLH, Ng SC, Lee V, Au KWL, Cheong PK, Suen BY, Chan H, Kee KM, Lo A, Wong VWS, Wu JCY, Kyaw MH.

Lancet. 2017 Jun 17;389(10087):2375-2382. doi: 10.1016/S0140-6736(17)30981-9. Epub 2017 Apr 11.

PMID:
28410791
36.

Single-Cell 5-Formylcytosine Landscapes of Mammalian Early Embryos and ESCs at Single-Base Resolution.

Zhu C, Gao Y, Guo H, Xia B, Song J, Wu X, Zeng H, Kee K, Tang F, Yi C.

Cell Stem Cell. 2017 May 4;20(5):720-731.e5. doi: 10.1016/j.stem.2017.02.013. Epub 2017 Mar 23.

37.

Albumin-Bilirubin grade predicts prognosis of HCC patients with sorafenib use.

Kuo YH, Wang JH, Hung CH, Rau KM, Wu IP, Chen CH, Kee KM, Hu TH, Lu SN.

J Gastroenterol Hepatol. 2017 Dec;32(12):1975-1981. doi: 10.1111/jgh.13783.

PMID:
28295594
38.

Whole-exome sequencing identified a homozygous BRDT mutation in a patient with acephalic spermatozoa.

Li L, Sha Y, Wang X, Li P, Wang J, Kee K, Wang B.

Oncotarget. 2017 Mar 21;8(12):19914-19922. doi: 10.18632/oncotarget.15251.

39.

Diagnostic efficacy of ultrasound in hepatocellular carcinoma diagnosis.

Kee KM, Lu SN.

Expert Rev Gastroenterol Hepatol. 2017 Apr;11(4):277-279. doi: 10.1080/17474124.2017.1292126. Epub 2017 Feb 15. Review. No abstract available.

PMID:
28162003
40.

An inducible CRISPR-ON system for controllable gene activation in human pluripotent stem cells.

Guo J, Ma D, Huang R, Ming J, Ye M, Kee K, Xie Z, Na J.

Protein Cell. 2017 May;8(5):379-393. doi: 10.1007/s13238-016-0360-8. Epub 2017 Jan 23.

41.

Sleep apnoea in heart failure: To treat or not to treat?

Naughton MT, Kee K.

Respirology. 2017 Feb;22(2):217-229. doi: 10.1111/resp.12964. Epub 2016 Dec 20. Review.

42.

Reply: Can Dead Space Ventilation Really Be Measured without PaCO2?

Kee K, Stuart-Andrews C, Ellis MJ, Wrobel JP, Nilsen K, Thompson BR, Naughton MT.

Am J Respir Crit Care Med. 2016 Dec 15;194(12):1556-1557. No abstract available.

PMID:
27976939
43.

Factors Predicting HBsAg Seroclearance and Alanine Transaminase Elevation in HBeAg-Negative Hepatitis B Virus-Infected Patients with Persistently Normal Liver Function.

Chien TL, Wang JH, Kee KM, Chen CH, Hung CH, Lu SN.

PLoS One. 2016 Dec 9;11(12):e0166543. doi: 10.1371/journal.pone.0166543. eCollection 2016.

44.

A homozygous NOBOX truncating variant causes defective transcriptional activation and leads to primary ovarian insufficiency.

Li L, Wang B, Zhang W, Chen B, Luo M, Wang J, Wang X, Cao Y, Kee K.

Hum Reprod. 2017 Jan;32(1):248-255. Epub 2016 Nov 11.

PMID:
27836978
45.

Engaging Adolescents Through Participatory and Qualitative Research Methods to Develop a Digital Communication Intervention to Reduce Adolescent Obesity.

Livingood WC, Monticalvo D, Bernhardt JM, Wells KT, Harris T, Kee K, Hayes J, George D, Woodhouse LD.

Health Educ Behav. 2017 Aug;44(4):570-580. doi: 10.1177/1090198116677216. Epub 2016 Nov 2.

PMID:
27811164
46.

Control theory prediction of resolved Cheyne-Stokes respiration in heart failure.

Sands SA, Edwards BA, Kee K, Stuart-Andrews C, Skuza EM, Roebuck T, Turton A, Hamilton GS, Naughton MT, Berger PJ.

Eur Respir J. 2016 Nov;48(5):1351-1359. doi: 10.1183/13993003.00615-2016. Epub 2016 Sep 1.

47.

Involvement of DR4/JNK pathway-mediated autophagy in acquired TRAIL resistance in HepG2 cells.

Lim SC, Jeon HJ, Kee KH, Lee MJ, Hong R, Han SI.

Int J Oncol. 2016 Nov;49(5):1983-1990. doi: 10.3892/ijo.2016.3699. Epub 2016 Sep 20.

PMID:
27665736
48.

Generating a Genome Editing Nuclease for Targeted Mutagenesis in Human Cells.

He Z, Kee K.

Methods Mol Biol. 2017;1498:153-162.

PMID:
27709574
49.

Reply: Dyspnea in Heart Failure: A Multiheaded Beast.

Kee K, Stuart-Andrews C, Ellis MJ, Wrobel JP, Nilsen K, Thompson BR, Naughton MT.

Am J Respir Crit Care Med. 2016 Sep 15;194(6):775-6. doi: 10.1164/rccm.201604-0837LE. No abstract available.

PMID:
27628084
50.

Allelic reprogramming of the histone modification H3K4me3 in early mammalian development.

Zhang B, Zheng H, Huang B, Li W, Xiang Y, Peng X, Ming J, Wu X, Zhang Y, Xu Q, Liu W, Kou X, Zhao Y, He W, Li C, Chen B, Li Y, Wang Q, Ma J, Yin Q, Kee K, Meng A, Gao S, Xu F, Na J, Xie W.

Nature. 2016 Sep 22;537(7621):553-557. doi: 10.1038/nature19361. Epub 2016 Sep 14.

PMID:
27626382

Supplemental Content

Support Center